| A survey study to characterize use of Spice products (synthetic cannabinoids) R Vandrey, KE Dunn, JA Fry, ER Girling Drug and alcohol dependence 120 (1-3), 238-241, 2012 | 457 | 2012 |
| Why aren't physicians prescribing more buprenorphine? AS Huhn, KE Dunn Journal of Substance Abuse Treatment 78, 1-7, 2017 | 323 | 2017 |
| A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence RZ Litten, ML Ryan, JB Fertig, DE Falk, B Johnson, KE Dunn, AI Green, ... Journal of addiction medicine 7 (4), 277-286, 2013 | 278 | 2013 |
| Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic A Garcia-Romeu, DJ Cox, KE Smith, KE Dunn, RR Griffiths Drug and alcohol dependence 208, 107849, 2020 | 164 | 2020 |
| Sleep deprivation impairs hippocampus‐mediated contextual learning but not amygdala‐mediated cued learning in rats DN Ruskin, C Liu, KE Dunn, NG Bazan, GJ LaHoste European Journal of Neuroscience 19 (11), 3121-3124, 2004 | 138 | 2004 |
| A hidden aspect of the US opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder AS Huhn, EC Strain, DA Tompkins, KE Dunn Drug and alcohol dependence 193, 142-147, 2018 | 135 | 2018 |
| Buprenorphine in the United States: Motives for abuse, misuse, and diversion HD Chilcoat, HR Amick, MR Sherwood, KE Dunn Journal of substance abuse treatment 104, 148-157, 2019 | 111 | 2019 |
| Sex‐Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder AS Huhn, MS Berry, KE Dunn The American journal on addictions 28 (4), 246-261, 2019 | 105 | 2019 |
| Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl NB Varshneya, AP Thakrar, JG Hobelmann, KE Dunn, AS Huhn Journal of addiction medicine, 2022 | 104 | 2022 |
| A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers SC Sigmon, KE Dunn, K Saulsgiver, ME Patrick, GJ Badger, SH Heil, ... JAMA psychiatry 70 (12), 1347-1354, 2013 | 104 | 2013 |
| Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting KE Dunn, FS Barrett, C Yepez-Laubach, AC Meyer, BJ Hruska, K Petrush, ... Journal of substance abuse treatment 71, 1-7, 2016 | 91 | 2016 |
| Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine/naloxone D Antoine, AS Huhn, EC Strain, G Turner, J Jardot, AS Hammond, ... The American Journal on Addictions 30 (1), 83-87, 2021 | 88 | 2021 |
| Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients KE Dunn, PH Finan, DA Tompkins, EC Strain Addictive Behaviors 76, 8-14, 2018 | 87 | 2018 |
| Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States AS Huhn, JG Hobelmann, JC Strickland, GA Oyler, CL Bergeria, ... JAMA Network Open 3 (2), e1920843-e1920843, 2020 | 83 | 2020 |
| A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. KE Dunn, SC Sigmon, EF Reimann, GJ Badger, SH Heil, ST Higgins Experimental and clinical psychopharmacology 18 (1), 37, 2010 | 82 | 2010 |
| Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety DE Falk, ML Ryan, JB Fertig, EG Devine, R Cruz, ES Brown, H Burns, ... Alcoholism: Clinical and Experimental Research 43 (1), 158-169, 2019 | 76 | 2019 |
| Severity and Interference of Chronic Pain in Methadone‐Maintained Outpatients KE Dunn, RK Brooner, MR Clark Pain Medicine 15 (9), 1540-1548, 2014 | 76 | 2014 |
| VOUCHER‐BASED CONTINGENT REINFORCEMENT OF SMOKING ABSTINENCE AMONG METHADONE‐MAINTAINED PATIENTS: A PILOT STUDY KE Dunn, SC Sigmon, CS Thomas, SH Heil, ST Higgins Journal of applied behavior analysis 41 (4), 527-538, 2008 | 75 | 2008 |
| A phase 2, double-blind, placebo-controlled randomized trial assessing the efficacy of ABT-436, a novel V1b receptor antagonist, for alcohol dependence ML Ryan, DE Falk, JB Fertig, B Rendenbach-Mueller, DA Katz, KA Tracy, ... Neuropsychopharmacology 42 (5), 1012-1023, 2017 | 72 | 2017 |
| Eliminating the adrenal stress response does not affect sleep deprivation-induced acquisition deficits in the water maze DN Ruskin, KE Dunn, I Billiot, NG Bazan, GJ LaHoste Life sciences 78 (24), 2833-2838, 2006 | 71 | 2006 |